
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Virtue is a healthcare venture capital firm founded in 2021 and based in Austin, Texas. The firm focuses on investing in the earliest stages of healthcare ventures, particularly those that leverage modern technology to address significant challenges in the healthcare ecosystem. Virtue has a total of approximately $87 million in assets under management, which includes Fund I of $31.25 million and Fund II of $55.75 million. The firm typically invests between $500,000 and $4 million in initial funding rounds.
Since its inception, Virtue has built a portfolio of 24 companies, emphasizing support for elite founders who aim to innovate within the healthcare sector. The firm is recognized for its fast decision-making process, often committing as the first investor in a funding round. This approach allows Virtue to provide timely support to startups in a rapidly evolving industry.
Virtue's notable milestones include its establishment as a key player in early-stage healthcare investments and its commitment to transforming the healthcare ecosystem through innovative solutions. The firm operates primarily within the United States, targeting ventures that can significantly impact healthcare delivery, administration, and data management.
Virtue invests primarily in healthcare-related ventures at the pre-seed and seed stages. The firm emphasizes innovative solutions that can significantly impact healthcare delivery, administration, insurance, data management, and clinical operations. The investment range is between $500,000 and $4 million, allowing for flexibility in supporting startups at various stages of their development.
The firm is particularly interested in sectors such as digital health and healthcare technology, seeking to back technical founders who understand both the challenges within the healthcare system and the potential of modern technology to address these issues. Virtue's investment thesis revolves around supporting elite founders who aim to transform the healthcare ecosystem through their innovative solutions.
Virtue's approach includes a preference for fast decision-making, typically providing commitments within 7-10 days. This rapid response time is a key differentiator for the firm, allowing it to act quickly in a competitive investment landscape. The firm also values collaboration and seeks to build strong relationships with its portfolio companies, providing access to a network of resources that can help accelerate growth and innovation.
Virtue's portfolio consists of 24 companies, each focusing on unique healthcare solutions. Notable portfolio companies include:
Each of these companies represents Virtue's commitment to investing in innovative healthcare solutions that can significantly improve various aspects of the healthcare system. The firm has not yet reported any confirmed exits or unicorns, as its portfolio primarily consists of early-stage ventures.
Sean Doolan: Co-founder of Virtue, Sean has a background in healthcare investment and entrepreneurship. He has led multiple funding rounds in the healthcare sector and is known for his expertise in identifying innovative healthcare solutions.
Emre Karatas: Co-founder of Virtue, Emre brings extensive experience in venture capital and healthcare technology. He has a strong track record of supporting early-stage healthcare ventures and is focused on leveraging technology to improve healthcare delivery.
To pitch to Virtue, founders should visit their website at virtuevc.com. The firm does not specify a formal application process, but it is recommended to include a clear overview of the business model, market opportunity, and team background in the pitch deck. Founders should expect a response within 7-10 days, as Virtue typically makes quick decisions.
Warm introductions are not explicitly required, but they can enhance the chances of getting noticed. Founders are encouraged to reach out through the contact options available on the website.
In the past year, Virtue has made four new investments, continuing its active deployment from Fund II, which has a total size of $55.75 million. The firm has completed a total of 24 investments since its founding in 2021, focusing on early-stage healthcare ventures.
Virtue's rapid decision-making process, typically committing within 7-10 days, has positioned it as a valuable partner for startups in the healthcare sector. The firm has not reported any confirmed exits or unicorns yet, as its portfolio primarily consists of early-stage companies.
What are Virtue's investment criteria?
Virtue primarily invests in healthcare-related ventures at the pre-seed and seed stages. The firm looks for innovative solutions that can significantly impact healthcare delivery, administration, and data management.
How can I apply or pitch to Virtue?
Founders can pitch to Virtue by visiting their website at virtuevc.com. The firm does not specify a formal application process, but interested parties are encouraged to reach out through the contact options available on their site.
What makes Virtue different from other venture capital firms?
Virtue differentiates itself through its focus on early-stage healthcare investments and its rapid decision-making process, typically committing within 7-10 days. This allows them to be the first investor in many funding rounds.
What is Virtue's geographic scope?
Virtue primarily operates within the United States, targeting healthcare ventures that can leverage modern technology to address significant challenges in the healthcare ecosystem.
What is the typical fund size and check size for Virtue?
Virtue has a total fund size of approximately $87 million, with individual check sizes ranging from $500,000 to $4 million for initial funding rounds.
What kind of post-investment involvement does Virtue have?
Virtue supports its portfolio companies with deep industry knowledge and access to a network of resources that can help accelerate growth and innovation in the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.